Efficacy, safety, and tolerability of a monoclonal antibody to proprotein convertase subtilisin/kexin type 9 in combination with a statin in patients with hypercholesterolaemia (LAPLACE-TIMI 57): a randomised, placebo-controlled, dose-ranging, phase 2 study-Reference-Cited by-同舟云学术

Efficacy, safety, and tolerability of a monoclonal antibody to proprotein convertase subtilisin/kexin type 9 in combination with a statin in patients with hypercholesterolaemia (LAPLACE-TIMI 57): a randomised, placebo-controlled, dose-ranging, phase 2 study

Published:2012-12 Issue:9858 Volume:380 Page:2007-2017
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Giugliano Robert P,Desai Nihar R,Kohli Payal,Rogers William J,Somaratne Ransi,Huang Fannie,Liu Thomas,Mohanavelu Satishkumar,Hoffman Elaine B,McDonald Shannon T,Abrahamsen Timothy E,Wasserman Scott M,Scott Robert,Sabatine Marc S

Publisher

Elsevier BV

Subject

General Medicine

Reference17 articles.

1. Optimal low-density lipoprotein is 50 to 70 mg/dl: lower is better and physiologically normal;O'Keefe;J Am Coll Cardiol,2004

2. Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials;Baigent;Lancet,2010

3. Lipid treatment assessment project 2: a multinational survey to evaluate the proportion of patients achieving low-density lipoprotein cholesterol goals;Waters;Circulation,2009

4. Reduction in Recurrent Cardiovascular Events With Intensive Lipid-Lowering Statin Therapy Compared With Moderate Lipid-Lowering Statin Therapy After Acute Coronary Syndromes

5. Proprotein convertases in health and disease;Artenstein;N Engl J Med,2011

Cited by 384 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and safety of ongericimab given by prefilled syringe or autoinjector in primary hypercholesterolemia and mixed hyperlipidemia;Nutrition, Metabolism and Cardiovascular Diseases;2024-09

2. PCSK9 inhibitors and inclisiran with or without statin therapy on incident muscle symptoms and creatine kinase: a systematic review and network meta-analysis;Frontiers in Cardiovascular Medicine;2024-07-08

3. PCSK9 Inhibitors and Infection-Related Adverse Events: A Pharmacovigilance Study Using the World Health Organization VigiBase;Drugs - Real World Outcomes;2024-07-02

4. Quantitative assessment of baseline imbalances in evolocumab and alirocumab trials: a meta-epidemiological study;BMC Medical Research Methodology;2024-06-22

5. Cancer and Cardiovascular Disease: The Conjoined Twins;Cancers;2024-04-09